Filing Details
- Accession Number:
- 0001209191-21-060101
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-08 17:59:27
- Reporting Period:
- 2021-10-07
- Accepted Time:
- 2021-10-08 17:59:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1029142 | Dynavax Technologies Corp | DVAX | Pharmaceutical Preparations (2834) | 330728374 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1573072 | F David Novack | C/O Dynavax Technologies 2100 Powell Street, Suite 900 Emeryville CA 94608 | President & Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-10-07 | 3,000 | $18.00 | 64,066 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 1, 2021.
- All shares were sold at $18.00
Billionaire Hedge Funds
